This is our first report on Healthcare Triangle and we look to provide a detailed account of the various drivers that will be responsible for the company’s growth in the coming years. The company is one of the most undervalued healthcare tech companies today. It had its initial public offering before this year, offering 8 million shares for $5 per share. However, their stock is trading below $2 per share in a typical post-listing selloff. From a valuation perspective, it is now trading at a bare ....
22 Jan 2022
Healthcare Triangle Inc. - Investment Thesis, Key Drivers, Financial & Price Forecasts, DCF Valuation
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Healthcare Triangle Inc. - Investment Thesis, Key Drivers, Financial & Price Forecasts, DCF Valuation
- Published:
22 Jan 2022 -
Author:
Ishan Majumdar -
Pages:
26
This is our first report on Healthcare Triangle and we look to provide a detailed account of the various drivers that will be responsible for the company’s growth in the coming years. The company is one of the most undervalued healthcare tech companies today. It had its initial public offering before this year, offering 8 million shares for $5 per share. However, their stock is trading below $2 per share in a typical post-listing selloff. From a valuation perspective, it is now trading at a bare ....